Lung Cancer Clinical Trial

Feasibility Study Incorporating Lung Function Imaging Into Radiation Therapy for Lung Cancer Patients

Summary

The proposed study is in the field of thoracic radiation oncology where radiation therapy is used to treat lung cancer. The primary objective of the early phase clinical trial will be to evaluate the safety of performing functional avoidance radiation therapy for lung cancer patients using 4D computed tomography (4DCT) ventilation imaging.

View Full Description

Full Description

This study plans to learn more about radiation therapy. Radiation therapy is one of the main treatments used to treat lung cancer. One of the known side effects of this radiation therapy is scarring of the lungs and reduced lung function that can result in shortness of breath. At this time the radiation treatment plan does not take into account differences in lung function between one part of the lung and another. Studies have shown that lung function can vary substantially throughout the lungs. This study aims to plan the radiation therapy to be away from the highest functioning portions of lungs while still delivering the intended radiation dose to the tumor. This study will allow researchers to determine whether taking lung function information into account when designing radiation treatment plans can protect lung function after radiation therapy.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Diagnosis of pathologically confirmed lung cancer by tumor biopsy and/or fine-need aspiration
Lung Cancer patients that will undergo definitive radiation therapy defined as 45-75 Gy as part of standard of care for their disease
18 years of age or older
Signed informed consent
Planned curative intent chemotherapy, delivered concurrently or sequentially in combination with radiotherapy
The patient's 4DCT-ventilation image meets image heterogeneity criteria

Exclusion Criteria:

Patients receiving Stereotactic Body Radiation Therapy
Patient receiving palliative radiation therapy (defined as less than 45 Gy)

Study is for people with:

Lung Cancer

Estimated Enrollment:

101

Study ID:

NCT02528942

Recruitment Status:

Completed

Sponsor:

University of Colorado, Denver

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

University of Colorado Cancer Center
Aurora Colorado, 80045, United States
Beaumont Health System
Royal Oak Michigan, 48085, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

101

Study ID:

NCT02528942

Recruitment Status:

Completed

Sponsor:


University of Colorado, Denver

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider